|
|
Madrid, 1-3 November
2005 -
Helsinn announces that it will attend the
forthcoming
CPhI Worldwide 2005, hosted at the
Feira de Madrid in Spain, 1 – 3 November 2005. As always, the event is expected
to welcome over 20.000 pharmaceutical decision makers from over 110 countries,
generating an ideal environment for new potential business deals.
Helsinn will actively participate in the leading event in the field of pharma
chemicals with its sponsored exhibition booth # 9G12,
Hall 9, focused on its strategic approaches to the market through:
- Integrating
Manufacturing: as qualified developer and producer of cGMP
Advanced Intermediates, Active Pharmaceutical Ingredients, High Potency
Active Ingredients, in its state-of-the-art facilities in Switzerland and
Ireland. Services also include full regulatory support and management of the
CMC part if needed.
Drug product development and manufacturing is also offered through the
collaborative Alliance with Cardinal Health providing a complete integrated
service for virtual pharma companies.
- Integrated
Licensing: by implementing an innovative approach to identify,
develop, produce and market new pharmaceutical products to satisfy unmet
medical needs in cancer supportive care and oncology, pain and inflammation
and gastroenterology areas. Products are selected through the identification
of potential in-licensing candidates at an early stage of clinical
development, and Out-of-Patent products to improve through new formulations,
new technologies or new indications. The development of the identified
products is then performed up to EU EMEA and US FDA standards and subsequent
approval to launch on the market through its established network of
partners. Scientific and market value is then added to the products,
offering our worldwide partners a leading edge with a complete package of
legal and technical services as well as scientific, regulatory and marketing
support, which ensure the commercial success during the complete life-cycle
of its products.
|
|